Nuvalent Inc (NUVL)
93.19
+2.02
(+2.22%)
USD |
NASDAQ |
Nov 21, 12:11
Nuvalent Price: 93.19 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 91.35 | 92.26 | 90.28 | 91.17 | 264769.0 |
| Nov 19, 2024 | 87.55 | 91.21 | 87.50 | 91.06 | 358451.0 |
| Nov 18, 2024 | 87.07 | 89.04 | 85.38 | 87.69 | 387310.0 |
| Nov 15, 2024 | 89.98 | 89.98 | 86.43 | 86.88 | 772969.0 |
| Nov 14, 2024 | 90.18 | 91.63 | 89.46 | 90.18 | 452524.0 |
| Nov 13, 2024 | 91.50 | 92.61 | 89.84 | 90.34 | 488979.0 |
| Nov 12, 2024 | 92.96 | 93.03 | 89.62 | 90.99 | 360076.0 |
| Nov 11, 2024 | 95.67 | 96.24 | 93.73 | 94.39 | 300623.0 |
| Nov 08, 2024 | 94.12 | 95.60 | 92.71 | 95.42 | 265249.0 |
| Nov 07, 2024 | 94.41 | 96.40 | 93.22 | 94.09 | 293912.0 |
| Nov 06, 2024 | 96.00 | 96.30 | 92.56 | 94.09 | 518193.0 |
| Nov 05, 2024 | 88.70 | 92.12 | 88.48 | 91.91 | 382500.0 |
| Nov 04, 2024 | 88.63 | 90.04 | 87.30 | 89.53 | 486592.0 |
| Nov 01, 2024 | 89.00 | 91.30 | 87.25 | 89.22 | 755736.0 |
| Oct 31, 2024 | 89.41 | 91.14 | 87.54 | 88.49 | 806758.0 |
| Oct 30, 2024 | 90.58 | 91.09 | 89.24 | 90.24 | 468479.0 |
| Oct 29, 2024 | 92.70 | 92.89 | 90.70 | 90.92 | 426066.0 |
| Oct 28, 2024 | 91.49 | 93.48 | 90.26 | 92.69 | 681769.0 |
| Oct 25, 2024 | 93.66 | 95.06 | 90.16 | 90.70 | 499858.0 |
| Oct 24, 2024 | 93.00 | 95.30 | 91.95 | 93.63 | 628256.0 |
| Oct 23, 2024 | 97.50 | 98.01 | 93.03 | 93.71 | 1.360M |
| Oct 22, 2024 | 100.48 | 103.62 | 100.48 | 102.51 | 195612.0 |
| Oct 21, 2024 | 103.69 | 104.44 | 100.25 | 101.16 | 242614.0 |
| Oct 18, 2024 | 102.11 | 104.81 | 101.91 | 103.68 | 258461.0 |
| Oct 17, 2024 | 105.13 | 105.13 | 101.76 | 102.16 | 184115.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.40
Minimum
May 16 2022
112.17
Maximum
Sep 16 2024
43.41
Average
34.52
Median
Price Benchmarks
| Viking Therapeutics Inc | 53.19 |
| Bristol-Myers Squibb Co | 57.98 |
| Replimune Group Inc | 11.10 |
| Moderna Inc | 36.93 |
| NovaBay Pharmaceuticals Inc | 0.7026 |
Price Related Metrics
| Price to Book Value | 5.906 |
| Earnings Yield | -3.72% |
| Market Cap | 6.621B |